UCL has been awarded £10m to fast-track the development of new treatments for Alzheimer’s disease and other dementias.
Pancreatic cancer could be diagnosed up to two years earlier by screening for two tumour markers found in blood, according to BRC-supported research.
A drug developed by UCL researchers and granted orphan drug designation is one of the first to take part in the newly launched adaptive licensing pilot project to speed up patients’ access to new medicines.
The drug is the first treatment aimed at directly removing amyloid deposits from the tissues of people with the rare and usually fatal disease, systemic amyloidosis.
Researchers have started a major trial to see if drugs normally prescribed for motor neurone disease, heart disease and depression could be some of the first therapies in the world to halt disability progression in people with multiple sclerosis (MS).
UCL and the London School of Hygiene and Tropical Medicine have been awarded a grant of £7.5 million from the Higher Education Funding Council for England’s (HEFCE) Catalyst Fund to develop the Bloomsbury Research Institute, which aims to address the global challenge of infectious disease.